Cytosolic Sulfotransferase 2A1/SULT2A1 Antibody (OTI4D7) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-71326F
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunocytochemistry/ Immunofluorescence
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI4D7
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Full length recombinant protein of human Cytosolic Sulfotransferase 2A1/SULT2A1 (NP_003158) produced in HEK293T cells.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Cytosolic Sulfotransferase 2A1/SULT2A1 Antibody (OTI4D7) [FITC]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Cytosolic Sulfotransferase 2A1/SULT2A1
Alternate Names
DHEA-ST, DHEAS, hSTa, ST2A3, SULT2A1
Gene Symbol
SULT2A1
Additional Cytosolic Sulfotransferase 2A1/SULT2A1 Products
Product Documents for Cytosolic Sulfotransferase 2A1/SULT2A1 Antibody (OTI4D7) [FITC]
Product Specific Notices for Cytosolic Sulfotransferase 2A1/SULT2A1 Antibody (OTI4D7) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...